Literature DB >> 29046013

New insights into cardiotoxicity caused by chemotherapeutic agents.

David J Grieve1, Sean M Davidson2.   

Abstract

LINKED ARTICLES: This article is part of a themed section on New Insights into Cardiotoxicity Caused by Chemotherapeutic Agents. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.21/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29046013      PMCID： PMC5647177          DOI： 10.1111/bph.14025

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  13 in total

1.  Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.

Authors:  Youyou Zhao; Declan McLaughlin; Emma Robinson; Adam P Harvey; Michelle B Hookham; Ajay M Shah; Barbara J McDermott; David J Grieve
Journal:  Cancer Res       Date:  2010-09-30       Impact factor: 12.701

Review 2.  Reducing attrition in drug development: smart loading preclinical safety assessment.

Authors:  Ruth A Roberts; Stefan L Kavanagh; Howard R Mellor; Christopher E Pollard; Sally Robinson; Stefan J Platz
Journal:  Drug Discov Today       Date:  2013-11-21       Impact factor: 7.851

3.  5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1.

Authors:  Paola Altieri; Roberto Murialdo; Chiara Barisione; Edoardo Lazzarini; Silvano Garibaldi; Patrizia Fabbi; Clarissa Ruggeri; Silvia Borile; Federico Carbone; Andrea Armirotti; Marco Canepa; Alberto Ballestrero; Claudio Brunelli; Fabrizio Montecucco; Pietro Ameri; Paolo Spallarossa
Journal:  Br J Pharmacol       Date:  2017-02-22       Impact factor: 8.739

4.  New insights into cardiotoxicity caused by chemotherapeutic agents.

Authors:  David J Grieve; Sean M Davidson
Journal:  Br J Pharmacol       Date:  2017-11       Impact factor: 8.739

Review 5.  Trastuzumab cardiotoxicity: from clinical trials to experimental studies.

Authors:  Balazs T Nemeth; Zoltan V Varga; Wen Jin Wu; Pal Pacher
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

Review 6.  Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.

Authors:  Mitchel Tate; Aaron Chong; Emma Robinson; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

7.  Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.

Authors:  Declan McLaughlin; Youyou Zhao; Karla M O'Neill; Kevin S Edgar; Philip D Dunne; Anna M Kearney; David J Grieve; Barbara J McDermott
Journal:  Br J Pharmacol       Date:  2017-04-22       Impact factor: 8.739

Review 8.  Mitochondrial-Shaping Proteins in Cardiac Health and Disease - the Long and the Short of It!

Authors:  Sang-Bing Ong; Siavash Beikoghli Kalkhoran; Sauri Hernández-Reséndiz; Parisa Samangouei; Sang-Ging Ong; Derek John Hausenloy
Journal:  Cardiovasc Drugs Ther       Date:  2017-02       Impact factor: 3.727

Review 9.  Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

Authors:  Luca Sala; Milena Bellin; Christine L Mummery
Journal:  Br J Pharmacol       Date:  2016-09-20       Impact factor: 8.739

Review 10.  Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.

Authors:  Michelle W Bloom; Carine E Hamo; Daniela Cardinale; Bonnie Ky; Anju Nohria; Lea Baer; Hal Skopicki; Daniel J Lenihan; Mihai Gheorghiade; Alexander R Lyon; Javed Butler
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790
View more
  1 in total

1.  New insights into cardiotoxicity caused by chemotherapeutic agents.

Authors:  David J Grieve; Sean M Davidson
Journal:  Br J Pharmacol       Date:  2017-11       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.